Swedish Orphan Biovitrum AB (OSTO:SOBI)
kr 276.4 3 (1.1%) Market Cap: 93.94 Bil Enterprise Value: 112.63 Bil PE Ratio: 43.61 PB Ratio: 2.63 GF Score: 87/100

Q4 2023 Swedish Orphan Biovitrum AB (publ) Earnings Call Transcript

Feb 08, 2024 / 01:00PM GMT
Release Date Price: kr259.4 (-7.95%)
Operator

Ladies and gentlemen, welcome to the Q4 2023 Report Conference Call and Live Webcast. I am Sandra, the Chorus Call operator. (Operator Instructions) The conference is being recorded. (Operator Instructions) At this time, it's my pleasure to hand over to Guido Oelkers, CEO. Please go ahead, sir.

Guido Oelkers;publ;CEO;President
Swedish Orphan Biovitrum AB

()-&

Yes. Thank you so much, and hello, everyone. This is Guido, CEO of Sobi. We are delighted to welcome you into the Fourth quarter and Full Year 2023 Conference Call for investors and analysts. Overall, we can say that we are pleased with our performance in 2023, and the year has exceeded our expectations. We posted this presentation to sorbi.com earlier today. And with this, let's go to Slide #2.

We would like to remind you, as per usual of the forward-looking statement. And unless stated otherwise, we like making comments that mostly related to the fourth quarter, full year performance in 2023 at constant exchange rate in million Swedish krona.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot